
01:01:01
Have a question for any of our presenters? Just click the “Q&A” at the bottom of your Zoom screen.

01:04:12
#hormonal_IUS and #methodmix

01:04:40
Shoot. That went to everyone. Well, now everyone knows the hashtags :)

01:05:56
that's good, they can tweet about how much fun they're having today :)

01:14:58
Reminder: Have a question or comment for our presenter? Just click the “Q&A” at the bottom of your Zoom screen.

01:19:40
Thank you, Dr. Tony!

01:24:29
is it already available in the private sector in these countries?

01:27:09
Hi, thank you for these great questions. We’ll address them toward the end of the day (as they require us to consider the “big picture”).

01:27:23
Thanks Anupama, will ask this question when Anna and Tabitha are done

01:28:54
thanks!

01:30:35
thank you!

01:31:06
Anna and Tabitha, please feel free to “type answer” in the Q&A box

01:36:59
Thank you for your question. We will share it with the panelists.

01:37:27
Thank you for your question. We will share it with the panelists.

01:40:25
I see that Zambia on history of Method use shown different scenario. Any explanation if I did not missed?

01:42:18
Thank you for your question. We will share with the panelists.

01:49:53
Thank you for submitting your questions in the Q&A window. Our presenters will respond as soon as possible. Please keep the questions and comments coming!

01:51:41
To our “5 Questions” Presenters: when you are done presenting, take a look at the Q&A window and feel free to “Type Answer”

01:57:45
I can still hear

02:02:16
Great! Please let us know if you encounter any other issue.

02:03:04
Hi Maria, most women experience reduced bleeding. There are always a few exceptions.

02:04:00
Amplifying today’s conversation on Twitter? Use these hashtags: #hormonal_IUS and #methodchoice

02:12:53
If you’ve raised your hand, please type your question or comment into the Q&A window or this chat box. Thank you.

02:16:20
I'm curious about the menstrual bleeding volume between implant vs LNG IUS. Both features less including amenorrhea. Can the presenter provide additional insight into the Nigeria findings on use of amt of menstrual products?

02:16:49
Hi, I see your raised hand. Can I help?

02:17:12
Hi, I see your raised hand. Can I help?

02:17:29
Hi, I see your raised hand. Can I help?

02:18:24
thanks Kate. WIll be in touch with the self removal and the learning agenda.

02:20:46
Great, thank Ricky!

02:34:37
Hi Jen - yes, we provide additional information about the segmentation framework. Before the end of this session, we'll announce where resources will be posted online. Info will be there and we're also happy to discuss in detail

02:40:35
What were the total sale figures for eloira per year?

02:46:00
Pregna is open to partnering for research projects with support of products at a subsidized cost.

02:47:13
sales@pregna.com

02:47:56
Thanks supply panel! you were succinct, provided great info, and it aligned well with what went ahead

02:48:10
Check out the Hormonal IUS Access Portal: www.iusportal.org

02:48:49
Will there be a post-session check in with the panelist? Thanks!

02:49:19
Very Exciting!

02:49:23
Don’t miss tomorrow! If you have not yet registered, do so here: bit.ly/Hormonal-IUS

02:49:35
Wonderful job staying on time everyone!

02:49:56
Yes, we are participating in the currently open tender processes with USAID and UNFPA and we announced this move already in Nairobi last year https://www.nairobisummiticpd.org/commitment/bayer-stepping-its-commitment-towards-sdg-371

02:50:26
thanks

02:50:31
thank you frank! We hadn't seen that. great to have the link - thank you!

02:52:01
Thank you Nomi and to everyone who participated!

02:52:25
Thank you, everyone!

02:52:31
thank you !!

02:52:35
thanks everyone! great information!